Stonebridge Financial Group’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-60	Closed	-$997	–	239
2025 Q1	$997	Hold	60	–	–	﹤0.01%	822
2024 Q4	$1.1K	Buy	+60	New	+$1.1K	﹤0.01%	772